ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the ACADIA Pharmaceuticals Conference Call. My name is Lauren Cannon, and I'll be your coordinator for today.
Acadia Pharmaceuticals Inc (ACAD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 13,029 | $92,900 | -26% | 0.08% |
| 2. | Leucadia National Ian Cumming And Joseph Steinberg | 0 | $0 | 0% | |
| 3. | Neo Ivy Capital Renee Yao | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.65 | 259,109 | Large Shareholder, Director | 39,317,673 | 2023-05-24 | Filing | |
| $25.65 | 24,113 | Large Shareholder, Director | 3,610,443 | 2023-05-24 | Filing | |
| $25.51 | 28,878 | Large Shareholder, Director | 39,058,564 | 2023-05-24 | Filing | |
| $25.51 | 2,688 | Large Shareholder, Director | 3,586,330 | 2023-05-24 | Filing | |
| $25.27 | 218,171 | Large Shareholder, Director | 39,029,686 | 2023-05-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.60 | 1,327 | 23,526 | 2025-05-02 | Filing | ||
| $14.60 | 3,498 | 62,773 | 2025-05-02 | Filing | ||
| $14.82 | 2,708 | 59,456 | 2025-04-08 | Filing | ||
| $14.82 | 1,028 | 22,257 | 2025-04-08 | Filing | ||
| $17.05 | 1,095 | 21,275 | 2025-03-26 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 21,366,557 | $354,898,513 | 0.01% | |
| 2. | 3,663,145 | $60,844,838 | 0.1% | |
| 3. | 815,905 | $13,552,182 | 0.61% | |
| 4. | 804,390 | $13,360,918 | 0% | |
| 5. | 754,748 | $12,536,364 | 0.01% |
News See All
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
12 Best Nasdaq Stocks Under $20 to Buy Now
The Nasdaq has had a challenging start to 2025, with the index dropping nearly 12% YTD, as of March 13.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the ACADIA Pharmaceuticals Conference Call. My name is Shannon, and I will be your coordinator for today.
12 Best Medical Stocks To Buy Under $20
The medical industry plays a crucial role in ensuring the health and safety of populations.
10 Firms End 2024 Stronger With Impressive Gains
The Dow Jones Industrial Average dipped by 0.07 percent, the S&P 500 shed 0.43 percent, and the Nasdaq Composite declined by 0.90 percent.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Third Quarter 2024 ACADIA Pharmaceuticals Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Worst-Performing Growth Stocks in 2024
Economists anticipate modest US economic growth in the upcoming quarters, and some continue to caution that a mild recession could occur.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q2 2024 Earnings Call Transcript
Operator: Good day ladies and gentlemen, and thank you for standing by. Welcome to the ACADIA Pharmaceuticals Second Quarter 2024 Financial Results Conference Call.
7 Best Halal Stocks To Buy Now (Debt Free)
Islamic equity investing, also known as Halal investing, has gained significant traction recently as Muslim investors seek to align their financial decisions with their religious beliefs.